Summary
This prediction ended on 13.10.22 with a price of €15.62. The price of GSK plc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.56%. A total of €0.35 was paid as dividends for this prediction. Snowman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
GSK plc | -2.068% | -2.068% | 7.886% |
iShares Core DAX® | -1.785% | -1.250% | 11.664% |
iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% |
iShares Nikkei 225® | -4.028% | -3.746% | 17.142% |
iShares S&P 500 | -1.969% | 0.307% | 25.617% |
According to Snowman what are the pros and cons of GSK plc for the foreseeable future?
Pros
High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
Medium risks for its business
Market Leader or Top 3
Some uniques
Well known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons
Comments by Snowman for this prediction
In the thread GlaxoSmithKline plc diskutieren
Buy mit Kursziel 20,0
In the thread Trading GlaxoSmithKline plc
Buy beendet